Search research articles
Contact Us
Filters
Showing results (71-80 of 75) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 75 results.
Acta Neurologica Scandinavica
|
June 1, 1989
Tetrahydrobiopterin and Parkinson's disease
I C Dissing, F Güttler, H Pakkenberg, et al.
Neuroscience
|
November 9, 2007
The effect of age and gender on the volume and size distribution of neocortical neurons
A K Stark, M H Toft, H Pakkenberg, et al.
Acta Neurologica Scandinavica
|
May 1, 1976
Parkinson's disease treated with Sinemet or Madopar. A controlled multicenter trial
H Pakkenberg, E Birket-Smith, E Dupont, et al.
Journal of Neurology
|
December 2, 1975
Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial
U K Rinne, E Birket-Smith, E Dupont, et al.
Acta Neurologica Scandinavica
|
January 1, 1996
Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients
E Dupont, A Andersen, J Boas, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 75) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 75 results.
Acta Neurologica Scandinavica
|
June 1, 1989
Tetrahydrobiopterin and Parkinson's disease
I C Dissing, F Güttler, H Pakkenberg, et al.
Neuroscience
|
November 9, 2007
The effect of age and gender on the volume and size distribution of neocortical neurons
A K Stark, M H Toft, H Pakkenberg, et al.
Acta Neurologica Scandinavica
|
May 1, 1976
Parkinson's disease treated with Sinemet or Madopar. A controlled multicenter trial
H Pakkenberg, E Birket-Smith, E Dupont, et al.
Journal of Neurology
|
December 2, 1975
Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial
U K Rinne, E Birket-Smith, E Dupont, et al.
Acta Neurologica Scandinavica
|
January 1, 1996
Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients
E Dupont, A Andersen, J Boas, et al.
Page
of 8